NMPA Approval

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)

Approval Number

国药准字H20254116

Company江苏万高药业股份有限公司

Registration Date

May 13, 2025

Drug Information

Generic Name

沙格列汀二甲双胍缓释片(Ⅲ)

Dosage Form

片剂

Strength

每片含沙格列汀2.5mg和盐酸二甲双胍1000mg

Drug Type

化学药品

Registration Date

May 13, 2025

Company Information

Applicant Company

Company Name江苏万高药业股份有限公司

Company Address

江苏省海门经济技术开发区定海路688号

Manufacturing Company

Company Name江苏万高药业股份有限公司

Company Address

江苏省海门经济技术开发区定海路688号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

沙格列汀二甲双胍缓释片(Ⅲ) - NMPA 批准文号 | MedPath